Physician profile
Benjamin Goldman
NPI 1467019356
$3,308.12
in general payments reported to CMS, 2019-2025
9 companies · $479 in 2025
The $479 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $127 · 2021: $93.09 · 2022: $153 · 2023: $1,891 · 2024: $419 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,461 · Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,460.61 |
| Food and Beverage | $1,328.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,765.93 | 2023-2024 | Ams 700 Cxr Rte Kit, Ams 700 |
| Medtronic, INC. | $381.48 | 2021-2023 | Micra |
| Procept Biorobotics Corporation | $355.54 | 2025 | |
| Coloplast Corp | $280.41 | 2019-2023 | Porges Coloplast |
| Allergan, INC. | $127.36 | 2020 | |
| Innovation Technologies INC | $123.26 | 2025 | Irrisept |
| Urogen Pharma, INC. | $120.83 | 2024 | |
| Axonics, INC. | $100.29 | 2024 | Bulkamid |
| Ethicon US, LLC | $53.02 | 2024 | Vistaseal, Surgicel Nu-Knit, Evarrest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.